MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,284,063 | -12.2% | 275,550 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $1,461,700 | -25.4% | 273,215 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,959,274 | +9.0% | 273,260 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $1,796,804 | +95.7% | 267,780 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $918,000 | +18.8% | 265,424 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $773,000 | -67.4% | 261,953 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $2,372,000 | -43.0% | 269,274 | +3.9% | 0.00% | -50.0% |
| Q4 2021 | $4,161,000 | -22.6% | 259,279 | +1.0% | 0.00% | -50.0% |
| Q3 2021 | $5,378,000 | -19.7% | 256,838 | +3.0% | 0.00% | 0.0% |
| Q2 2021 | $6,695,000 | -10.6% | 249,256 | +6.1% | 0.00% | -20.0% |
| Q1 2021 | $7,485,000 | +63.7% | 235,000 | +17.5% | 0.01% | +66.7% |
| Q4 2020 | $4,572,000 | -4.2% | 200,008 | +5.6% | 0.00% | -25.0% |
| Q3 2020 | $4,774,000 | -6.4% | 189,487 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $5,099,000 | +298.0% | 182,606 | -17.0% | 0.00% | +300.0% |
| Q1 2020 | $1,281,000 | -56.4% | 220,094 | -18.5% | 0.00% | -50.0% |
| Q4 2019 | $2,936,000 | +5.0% | 269,926 | +23.2% | 0.00% | 0.0% |
| Q3 2019 | $2,796,000 | -29.8% | 219,143 | -6.7% | 0.00% | -50.0% |
| Q2 2019 | $3,985,000 | +21.2% | 234,832 | +28.4% | 0.00% | +33.3% |
| Q1 2019 | $3,288,000 | +63.2% | 182,880 | +15.3% | 0.00% | +50.0% |
| Q4 2018 | $2,015,000 | -40.6% | 158,661 | +0.3% | 0.00% | -33.3% |
| Q3 2018 | $3,392,000 | +6.6% | 158,205 | +2.6% | 0.00% | 0.0% |
| Q2 2018 | $3,183,000 | +51.1% | 154,121 | +84.1% | 0.00% | +50.0% |
| Q1 2018 | $2,106,000 | +32.5% | 83,714 | +0.1% | 0.00% | +100.0% |
| Q4 2017 | $1,589,000 | -24.7% | 83,606 | -26.7% | 0.00% | -50.0% |
| Q3 2017 | $2,109,000 | +6.2% | 114,125 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $1,986,000 | -5.8% | 113,425 | +0.1% | 0.00% | -33.3% |
| Q1 2017 | $2,108,000 | -10.3% | 113,342 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $2,351,000 | -31.3% | 115,042 | +0.6% | 0.00% | -25.0% |
| Q3 2016 | $3,421,000 | +11.8% | 114,385 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $3,061,000 | +40.2% | 113,400 | -2.6% | 0.00% | +33.3% |
| Q1 2016 | $2,183,000 | -39.4% | 116,400 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $3,605,000 | +51.5% | 116,400 | +4.8% | 0.01% | +25.0% |
| Q3 2015 | $2,380,000 | -42.8% | 111,100 | +1.5% | 0.00% | -33.3% |
| Q2 2015 | $4,158,000 | +32.5% | 109,500 | +9.5% | 0.01% | +20.0% |
| Q1 2015 | $3,137,000 | -16.6% | 100,000 | -6.7% | 0.01% | -16.7% |
| Q4 2014 | $3,760,000 | +59.2% | 107,200 | -5.1% | 0.01% | +50.0% |
| Q3 2014 | $2,362,000 | -3.8% | 113,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,455,000 | +16.4% | 113,000 | +49.1% | 0.00% | 0.0% |
| Q1 2014 | $2,110,000 | +1.5% | 75,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,079,000 | – | 75,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |